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Summary
Tritium-labeled dihydromorphine (DHM-3H) was accumulated in vitro
by the synaptosomal fraction (nerve endings) of rat cerebral cortex . Particles
derived from nerve endings by osmotic shock exhibited a higher concentration
o! DHM- 3H than did other subcellular fractions o! brain when the isolated
fractions were incubated with the dru~ in vitro. Nalorphine in large concen-
trations reduced the uptake of DHM- H~y~ractions to the same degree .
No diSerence was apparent in the uptake of DHM- 3H by subcellular factions
from non-tolerant and morphine-tolerant rats . The uptake of DHM- H by
nerve endings was attributed to a binding phenomenon, although an active
transport process may provide the drug an access to the binding sites in the
intact tissue .
IDENTIFICATION of specific sites and types of interaction of narcotic anal-
gesics with nervous tissue would facilitate studies of the nature of narcotic
analgesic receptors, increase our understanding of the interactions of narcotic
analgesics and their antagonists, and possibly provide clues to the cellular
mechanisms affected by these drugs. Accordingly, we are studying the
accumulation of narcotic analgesics by brain tissue in vitro where some o! the
variables affecting uptake o! drugs in vivo (e . g. , blood flow, plasma protein
binding, pH) can be eliminated or better controlled .
Earlier reports from our laboratory indicated that narcotic analgesics
are accumulated by brain tissue in vitro by a process with the characteristics
* A summary o! the results appeared in The Pharmacologist 11, 293, 1889.
t This investigation was supported in part by grant MH-08580 from the
National Institute of Mental Health .
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of active transportl' 2 and by binding of the drugs to tissue components . 3 In
the present report we describe the accumulation of a narcotic analgesic,
tritium-labeled dihydromorphine (DHM-3H), by synaptosomea and other aub-
cellular fractions of brain in vitro.
Methods
Isolation of synaptosomes from cerebral cortical slices incubated in
vitro. Cerebral cortical slices from male Holtzman rats were prepared and
incubated as described previously, 1 After incubation, each slice 1.20-40 mg
wet weight) was homogenized in 0. 7 ml of 0. 32 M sucrose. One-half ml of
the homogenate was layered over a 4. 5 ml continuous (linear, 0. 3-1 . 8 1VI)4' S
or a 4. 5 ml discontinuous (l . 5 ml each of 0. 8, 1 . 2, 1 . 8 M)6 gradient of
sucrose. Continuous gradients were centrifuged at Oo C for 90 min at
125, 700 x g (av) and discontinuous gradients at 51, 000 x g (av). Continuous
gradients were collected dropwise (0 . 15-0 . 2 ml portions) from the bottom of
the tube . In the discontinuous gradients three tissue layers were evident.
The three tissue layers and the Pour alternating layers of sucrose media were
removed individually by pipette. The tissue layers were suspended in glass
distilled water for subsequent analysis . All fractions were analysed for
radioactivity and protein.
Incubation of isolated synaptosomes . Homogenates of rat whole brain in
0. 32 M sucrose were centrifuged at 900 x g (max) x 10 min to remove nuclei
and unbroken cells. The supernate was centrifuged at 11, 500 x g (max) x 20
min to yield a pellet which was resuspended in 0. 32 M sucrose, layered over
a two-step gradient of sucrose (0. 8 and 1 . 2 M), and centrifuged at 63, 500 x g
(av) x 90 min. The tissue layer at the interface of 0. 8 and 1. 2 M sucrose
(synaptosomes) was mixed with an equal volume of distilled water and centri-
fuged at 105, 000 x g (max) x 40 min. The pellet was resuspended in the Krebs-
bicarbonate medium (pH 7. 4) used for incubating tissue slices . 1 The suapen-
sion was incubated at 37° C (with or without an inhibitor) 10 min before and
10 min after the addition of DHM- 3H (6. 7 Ci/mmol) or norepinephrine- 3H
(10 Ci/mmol) (New England Nuclear Corp . ) . At the end of the incubation
period the suspension was diluted with 3 volumes of ice-cold media and
centrifuged at 105, 000 x g (max) x 30 min at 0° C.
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Isolation and incubation of subcellular fractions from whole brain.
Whole brains of decapitated rats were removed and homogenized in ice-chilled
medium containing : 320 mM sucrose, 0. Ol mM CaC12 and 25 mM Trie-buffer
at pH e. 8. Subcellular fractions were prepared as described by De Robertis
and his co-workers. 7-10 The individual fractions containing 1 to 5 mg protein
were resuspended and incubated at 22-24° C for 30 minutes in 10 ml of the
sucrose-CaC12-Tris medium containing DHM-3H. After incubation, all tissue
fractions were sedimented at 105, 000 x g (max) x 30 min at 0° C.
Analysis of radioactivity and protein. Tubes containing tissue pellets
were drained of media overnight and then the walls were rinsed with distilled
water 4 times and the surface of the pellet once before resuspending the pellet
in distilled water for analysis o! radioactivity and protein.
Aliquots (0 . 05 to 0. 2 ml) of each gradient fraction and tissue suspension
were mixed with 3 ml absolute ethanol and 7 ml toluene-phosphor solution, 1
and the radioactivity was determined in a liquid scintillation spectrometer .
An internal standard of toluene-3H was used to determine quenching. Cerebral
cortical slices and whole brain homogenates were incubated with DHM- 3H and
then subjected to chromatographic analysis as described previously . 1 In
each case, only unchanged DHM- 3H was detected.
Protein determinations were performed as described by Lowry et al . 11
Characterization of the subcellular fractions. Deoxyribonucleic acid
was estimated by the method of Burton . Enzymatic activity was determined
!or auccinate-INT-reductase, 13 NADPH-cytochrome C reductase l4 and
acetylcholine esterase .
15
Accumulation of norepinephrine- 3H was determined
for cerebral cortical slices4' Sand for isolated synaptosomes .
8
Analysis of data. Concentrations of DHM- 3H and norepinephrine- 3H
were expressed as pmoles per mg of protein in the tissue fractions. The
effect of a potential inhibitor was determined by comparing the concentration
of DAM- 3H in a sample of tissue incubated without an inhibitor (control) to
the concentration in another sample of the same tissue obtained from the same
animal and incubated at the same time with the inhibitor. The results with the
inhibitor were expressed as percent of control and were analysed statistically
ae a paired comparison. S. E. M. refers to standard error of the mean for the
number of animals (n) studied.
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Results
Uptake of DHM- 3H by cerebral cortical slices. When rat cerebral
cortical slices were first incubated with DHM- 3H (1 uM) for 10 min at 37° C
and then homogenized and centrifuged on a continuous gradient of sucrose,
approximately 28°J6 of the radioactivity was associated with the synaptosomal
layer and moat of the remainder of the radioactivity was recovered in the
soluble fraction (Fig. 1). A similar distribution of radioactivity was seen
when the slices were incubated with 0. 04 pM norepinephrine- 3H (Fig . 1), in
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Subcellular distribution of radioactivity in rat cer bral cortical
slices incubated with DHM-3H or norepinephrine-~H. (Continuous
gradient; see text for details. ) Similar results were obtained in
three other experiments.
Discontinuous sucrose gradients were used to improve the separation of
the fractions of cerebral cortical slices incubated with DHM- 3H. About 2586
of the radioactivity was associated with the synaptosomal fraction (Lr2), 5g6
with the nuclear-mitochondrial fraction (Lr 1) and 6586 with the soluble fraction
(Fig. 2) . Although a third tissue fraction (Lr3, microeomes and myelin)
could be distinguished visually we did not attempt to separate its content of
radioactivity from that of the soluble fraction . The total recovery of radio-
activity from the gradient was cJ9. 9% of that originally present in the slice.
In (`figure 3, the distribution of DHM- 3H, norepinephrine- 3H, and several
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Fig. 2
Subcellular distribution o! DHM-~H .in rat cerebral cortical slices.
(A discontinuous gradient coIIected dropwise from the bottom of
the tube .
	
See text for detaüs. ) The contents of the fractions Lrl,
L-2 and U3 are shown in Fig. 3. Similar patterns of distribution
were seen in two additional experiments.
Fig. 3.
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Distributign of radioactivity and enzymatic activity in subcellular
fractions of rat cerebral cortical slices. The fractions designated
Lrl, Ir2~nd USS FYg. 2 were analysed for DHM-sH, norepi-
nephrine- H (NE- H) acetylcholinesterase (Ach Est), succinate-
INT-reductase (TNT Red) and NADPH-cytochrome C reductase (Cyt
C Red) activities . In each case, the fraction showing the highest
activity (counts or OD per min per mg protein) was assigned a value
of 10096 and the other !racoons were compared to it. Each bar
represents the mean of values obtained in three different experiments.
aoa
~ 40
enzyme activities are shown. The fractions are compared on the basis of
activity per mg of protein for each constituent. There is about a a-fold greater
concentration of DHM- 3H in the synaptosomal layer compared to the nuclear-
mitochondrial layer. The very high values for the whole homogenate are due
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to its large content of free DHM- 3H. # The distribution of enzymatic activities
among the fractions is an indication o! the separation and identity of the
fractions. Succincte-INTt-reductase was used as a mitochondrial marker, 18
NADPH-cytochrome C reductase as a microsomal marker, 17 and acetylcholine
esterase? and norepinephrine uptake4' 5 as synaptosomal markers.
When cerebral cortical slices were incubated in the presence of nal-
orphine or ouabain the uptake of DHM- 3H by the slices and their constituent
aubcellular fractions was reduced significantly (Table 1). In the case of nal
orphine, the degree of reduction was similar !or the slice and its constituent
fractions.
Uptake of DHM- 3H and norepinephrine- 3H by isolated eynaptosomes .
Synaptoeomes were isolated from rat whole brain and then incubated with
DHM- 3H and norepinephrine- 3H (Table 2). DHM- 3H accumulation was de
pressed by the low temperature and in the presence o! either nalorphine or
naloxone; it was unaffected by ouabain. The uptake of norepinephrine was
reduced at 0° C and by ouabain.
Uptake of DHM- 3H b~ isolated aubcellular fractions.	Subce l lar
fractions isolated according to the methods of De Robertis _et _a1
7-10 were
characterized biochemically (Table 3) . Studies of the uptake of DHM- 3H by
the individual fractions incubated separately with the drug are summarized in
Table 4. The data are expressed as the specific binding ratio (SHR) as defined
by Azcurra and De Robertis .
7
Relatively higher concentrations o! DHM- 3H
were found in the Ml 0. 8, Ml 0. 9, Ml 1 . 0 and MZ fractions. Although all
fractions released DHM- 3H when resuspended in fresh media, these four
fractions retained relatively more DHM- 3H as indicated by the increase in
their SBR values (Table 4) .
Preliminary studies with subcellular fractions from morphine-tolerant
and dependent rats (which received morphine 33 mg/kg aubcutaneously or
intraperitoneally every 8 hours for 1-3 months) did not reveal any striking
change in the pattern of DHM-3H distribution among the fractions when they
were incubated individually with the radioactive drug (Table 4) .
Nalurphinc in a concentration of 1 mM in the medium reduced the binding
Appruximatcly 85°J° of the dihydromorphine in the soluble fraction of a homo-
grnate crf cerebral cortical slices incubated with the drug (1 pM) was present
in arr ultrafiltratc crf the homogenate .
i INT. 2-(1~-iodophenyl)-3-(p-nitruphenyl )-5-phenyltetrazolium chloride .
vol . lo, No. 4
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TABLE 1
Uptake o! DHM- 3H by rat cerebral cortical slices
* Jntact cerebral cortical slices were incubated with DHM- 3H (1 pM) and
then homogenized and applied to a discontinuous sucrose gradient .
** This value is for total DHM-3H (i, e. , free and bound) preset in an aliquot
taken from the slice homogenate before it was layered over the sucrose
gradient.
#**We have previously demonstrated s significant reàuction o! DHM- 3H uptake
by whole cerebral cortical slices incubated in the presence o! nalorphine
under the ~ame experimental conditions (8B t 2y6 of control, n = 18,
p < . 001).
TABLE 2
Uptake o! DHM- 3H and norepinephrine- 3H by isolated synaptosomes
+ p< .02, ++ p< .001
* The concentration o! DHM- 3H was 1 pM in the media and 123 t 8 pmola/ mg
of protein in the synaptoeomal fraction (n = 8).
**The concentration o! norepinephrine- 3H was 0 . 04 pM in the media and
42 t 3 pmols/mg of protein in the synaptosomal fraction (n = 3) .






t S. E. M.
Ouabain (1 mM)
Whole homogenate 4 94 1 8 ** 80 1 7 *~* 79 t 8+
Synaptosomes 4 41 1 2 79 1 5+ 58 1 8++
Mitochondria +
Nuclei 4 24 1 1 79 1 8+ 58 1 3+++






Control t S. E. M.
Norepinephrine-3H** n
Temperature (0° C) 72 f 1++ 8 14 t 2++ 3
Ouabain 1 mM 102 f 3 3 20 1 1++ 3
Nalorphine 1 mM 87 1 1+ 3 --- -
Naloxone 1 mM 88, 87 2 --- -
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TABLE 3
Characterization of aubcellular fractions o! rat whole brain
#According to Azcurra and De Robertis.
7
~ Specific activity ratio = enzymatic activity per mg protein in the specific
fraction/activity per mg protein in the total particulate fraction (TP).
of DHM-3H (0. 1 pM in the medium) to the total particulate fraction of rat
whole brain by 22 percent t 3 S. E. M. (n = 5, p < . Ol ). The degree of reduc-
tion was approximately the same (range of 14 to 24 percent) for each of the 10
subcellular fractions listed in Table 4. No difference in the pattern of distribu-
tion of DHM- 3H among the subcellular fractions was apparent in the presence
of nalorphine . Nalorphine in a concentration of 10 ~M had no effect on the
uptake of DHM- 3H (0 . 1 pM) by any of the subcellular fractions.
Discussion
Tritium-labeled dihydromorphine (DHM-3H) ie a narcotic analgesic very
similar to morphine in its physical, chemical and pharmacological properties
as well as in its disposition in the animal body . 18-23 In the present study we
have demonstrated that DHM- 3H was preferentially accumulated in vitro by
nerve endings (synaptosomes) as compared to other subcellular fractions of
T'he preferential uptake was evident when either cerebral corticalbrain.






(pg/mg of Protein) Reductaae Reductaee
t S. E. M.
C Acetylcholine
Esterase
TP 12. 7 f 0. 8 1 1 1
NUC 18.1 f0.8 1 .1 t0.02 1.4t0.1 0.8t0.1
MIC 1.6t0.3 0.4f0.01 10.3f2.2 2.Ot0.1
MIT 2.0f0.2 4.7t0.5 2.3t0.4 1.6t0.2
Contenta
Ml Mitochondria, myelin, synaptic membranes l . 6 f 0. i
0. 8 Myelin 1 . 8 t 0. 5
0. 9 Synaptic membranes, myelin 4. 0 t 0. 2
1 . 0 Synaptic membranes (cholinergic) 3. 2 t 0. 1
1 . 2 Synaptic membranes (non-cholinergic) 2. 1 t 0. 1
P Mitochondria 0. 7 t 0. 1
M2 Synaptic vesicles
2. 6 f 0. 2
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TABLE 4
Binding of dihydromorphine to isolated aubcellular fractions of
whole brain of non-dependent and morphine-dependent rats
Specific binding ratio = cpm per mg protein in the specific fraction/cpm
per mg protein in total particulate fraction (TP). Where n = 2, mean
SBR t range is listed, The concentration of DHM- 3H in the medium was
0. 1 uM.
7. 2 pmol DHM- 3H per mg of protein (n = 7).
~~* 1 . 9 pmol DHM- 3H per mg of protein (n = 7).
2. 0 pmol DHM- 3H per mg of protein (n = 7).
t Each fraction was twice reeuspended in fresh medium and sedimented. The
final pellet was resuapended in distilled water and analysed for radioactivity
and protein.
In four additional experiments the Ml 0. 9 and 1 . 0 fractions were analysed
together and the average SBR value was 2. 9 t . 59 .
liminary report by Scrafani et al 24 indicates that accumulation of DHM- 3H
by synaptosomes is also evident when the drug is administered to rats _in vivo.
In an earlier study, Mule _et a125 did not observe preferential accumu-
lation of morphine- 3H by nerve endings in the brains of guinea pigs injected
with the radioactive drug. Rather, they recovered the major portion of the
drug (88gô) from the soluble fraction and found the remainder distributed
rather evenly among the various particulate fractions of whole brain. How-
Specific Binding Ratio t S. E. M.
Non-dependent Morphine-dependent
Subcellular
Fraction n Unwashed n Washedt n Waehedt
TP _ ##1 -
l~~x* - ~~~*1
NUC 4 1 . 0 t . 04 3 0. 9 t . 00 2 0. 9 t . 08
MIC 11 1 . 1 t . 11 3 1 . 1 t . 20 2 0. 7 f . 02
MIT 8 1. 1 t . 08 2 1 . 2 * . Ol - ---
Ml 5 0.9t .05 2 1 .1t .13 2 1 .2t .Ol
0.8 7 1 .7t .08 5 2.7t .54 4 1.4f .08
0.9 7 1 .8t .18 2 2.4t .03* 2 2.0t .13
1 .0 7 1 .7t .14 3 2.8t .15$ 7 2.2f .08
1.2 7 1 .1f .10 2 1 .3t .41 2 1.3t .05
P 7 0.7f .11 2 1 .i t .50 2 1.8f .18
M2 11 1 .5t .05 7 2.l t .34 7 2.4t .34
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ever, the degree of washout and redistribution of morphine during the iso-
lation procedure was not evaluated. It is likely that washout was greater for
nerve ending particles than for other fractions since these particles were
subjected to a greater number of cycles of centrifugation and reauspenaion
and to osmotic shock. Several diSerent investigatora3' 19, 26, 27 have found
that the binding of morphine-like drugs to subcellular fractions of brain is
reduced by washing the tissue (i. e. , by resuspension or dialysis). In the
present study, 75 percent of the DHM- 3H was removed by just two cycles of
resuspenaion and centrifugation of the tissue fractions. However, in the
present study, all tissues were simultaneously subjected to exactly the same
manipulations and thus would be expected to be aßfected to the same degree .
The fact that certain nerve ending fractions (Ml 0. 8, Ml 0. 9, Ml 1 . 0 and M2 )
retained relatively more DHM- 3H after successive washings may indicate
that these particular fractions have a relatively greater affinity for the narcotic
analgesic. A careful kinetic analysis is required to evaluate fully the latter
possibility .
The mechanism of accumulation of DHM- 3H by nerve endings is not yet
totally clear, Participation of a passive process, probably binding to tissue
components, is suggested on the basis of the relatively large accumulation of
DHM- 3H in the synaptosomal fraction at low temperatures and because of the
preferential uptake of the drug by particles derived from nerve endings by
osmotic shock. Also, ouabain, in concentrations which markedly depressed
the uptake of norepinephrine, failed to reduce the uptake of DHM- 3H by
isolated synaptosomes . However, ouabain did depress the accumulation of
DHM-3H in cerebral cortical slicea l and in the synaptoaomal, nuclear and
mitochondrial fractions derived from slices incubated with the drug. Thus,
in the tissue slice, and possibly in the intact brain, a transport process may
provide the drug an access to the binding sites.
Nalorphine, the narcotic analgesic antagonist, consistently reduced the
uptake of DHM- 3H by all tissue iractiona, and the degree of reduction was
similar for the various iractiona. However, very large concentrations of
nalorphine were required in order to reduce the uptake of DHM- 3H and the
degree of reduction was small. Hence, several questions may be rained
concerning the biological significance of the findings. 1) Does the accumulation
of DIIM- 3H represent binding to specific receptor sites? The fact that nal-
Vol . 10, No. 4
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orphine reduced the binding of DHM3A to brain tissue but not to liver, kidney
or muscle3 may indicate an element of specificity, but it does not rule out a
large contribution o! non- specific sites to the overall uptake by brain. 2 ) Do
the narcotic analgesic antagonists and DAM- 3A bind and act at dülereat sites?
This possibility has been examined by a number o! iavestigatorsa8 and cannot
be ruled in or out with the data prese~ed here. 3) Do the alYinities o! DAM-3H
and narcotic antagonists !or the binding sites diüer? A careful kinetic aaaiysie
o! the binding o! DHM- 3H in the presence and absence o! the antagonists is
required to answer these. questions.
Although the data are insufficient to rule out small quantitative changes
in the binding o! narcotic analgesics to nerve endings with the development o!
tolerance and physical dependence, the results indicate that dramatic düfeaces
are not likely to be found with the techniques applied in the present study.
The biological signüicance of preferential accumulation of narcotic
analgesics by nerve endings may be considerablé in light of a number o!
reports relating the effects o! these drugs to their actions on synaptic
functions. To cite but a !ew examples : The turnover (i. e. , synthesis,
release or degradation) of catecholamines29' 30 and serotonin3l in the central
nervous system o! rodents has been altered by the administration of morphine
and other narcotic analgesics . Morphine-like drugs interfere with the release
o! acetylcholine from nerve endings in the gut, 32 from the brain o! the cat33
and rat34 in vivo and Prom cerebral cortical slices o! rat35 and mouse38 in
vitro. The findings related to acetylcholine are especially interesting since
DAM- 3H appeared to be preferentially accumulated in the Ml 1 . 0 fraction
which was identified by Azcurra and De Robertie7 as the one containing
cholinergic synaptic membranes. Aowever, as of the present time, none o!
the changes in nerve ending function have been established as the basis of
analgesia, tolerance, physical dependence or aqy other effect produced by
narcotic analgesics . Thus an understanding of the biological significance of
the uptake o! narcotic analgesics by nerve endings awaits further studies.
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